Selected research
Industry Research
Josamycin Industry Research Report 2026
Market perspective
The global Josamycin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Josamycin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Josamycin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Josamycin include Tosun Pharm, CSPC, SINE, Minsheng Pharma, BioChemPartner, Guilin Pharma, Bayer, Guanghua Pharma and SAJA Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Josamycin market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Josamycin Market by Company
Tosun Pharm
CSPC
SINE
Minsheng Pharma
BioChemPartner
Guilin Pharma
Bayer
Guanghua Pharma
SAJA Pharma
Ferrer International
Dragon Pharm
Astellas
Josamycin Segment by Type
99% Purity Type
98% Purity Type
95% Purity Type
Others
Josamycin Segment by Application
Josamycin Tablets
Propidinium Propionate Granule
Others
Josamycin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Josamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Josamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Josamycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Josamycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Josamycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Josamycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 99% Purity Type
- 98% Purity Type
- 95% Purity Type
- Others
Applications
- Josamycin Tablets
- Propidinium Propionate Granule
- Others
Companies covered
- Tosun Pharm
- CSPC
- SINE
- Minsheng Pharma
- BioChemPartner
- Guilin Pharma
- Bayer
- Guanghua Pharma
- SAJA Pharma
- Ferrer International
- Dragon Pharm
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Josamycin Market Size (2021-2032)
- 2.2.2 Global Josamycin Sales (2021-2032)
- 2.2.3 Global Josamycin Market Average Price (2021-2032)
- 2.3 Josamycin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 99% Purity Type
- 2.3.3 98% Purity Type
- 2.3.4 95% Purity Type
- 2.3.5 Others
- 2.4 Josamycin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Josamycin Tablets
- 2.4.3 Propidinium Propionate Granule
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Josamycin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Josamycin Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Josamycin Revenue of Manufacturers (2021-2026)
- 3.4 Global Josamycin Average Price by Manufacturers (2021-2026)
- 3.5 Global Josamycin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Josamycin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Josamycin, Product Type & Application
- 3.8 Global Manufacturers of Josamycin, Established Date
- 3.9 Global Josamycin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tosun Pharm
- 4.1.1 Tosun Pharm Company Information
- 4.1.2 Tosun Pharm Business Overview
- 4.1.3 Tosun Pharm Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tosun Pharm Josamycin Product Portfolio
- 4.1.5 Tosun Pharm Recent Developments
- 4.2 CSPC
- 4.2.1 CSPC Company Information
- 4.2.2 CSPC Business Overview
- 4.2.3 CSPC Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSPC Josamycin Product Portfolio
- 4.2.5 CSPC Recent Developments
- 4.3 SINE
- 4.3.1 SINE Company Information
- 4.3.2 SINE Business Overview
- 4.3.3 SINE Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SINE Josamycin Product Portfolio
- 4.3.5 SINE Recent Developments
- 4.4 Minsheng Pharma
- 4.4.1 Minsheng Pharma Company Information
- 4.4.2 Minsheng Pharma Business Overview
- 4.4.3 Minsheng Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Minsheng Pharma Josamycin Product Portfolio
- 4.4.5 Minsheng Pharma Recent Developments
- 4.5 BioChemPartner
- 4.5.1 BioChemPartner Company Information
- 4.5.2 BioChemPartner Business Overview
- 4.5.3 BioChemPartner Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BioChemPartner Josamycin Product Portfolio
- 4.5.5 BioChemPartner Recent Developments
- 4.6 Guilin Pharma
- 4.6.1 Guilin Pharma Company Information
- 4.6.2 Guilin Pharma Business Overview
- 4.6.3 Guilin Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guilin Pharma Josamycin Product Portfolio
- 4.6.5 Guilin Pharma Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Josamycin Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Guanghua Pharma
- 4.8.1 Guanghua Pharma Company Information
- 4.8.2 Guanghua Pharma Business Overview
- 4.8.3 Guanghua Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Guanghua Pharma Josamycin Product Portfolio
- 4.8.5 Guanghua Pharma Recent Developments
- 4.9 SAJA Pharma
- 4.9.1 SAJA Pharma Company Information
- 4.9.2 SAJA Pharma Business Overview
- 4.9.3 SAJA Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SAJA Pharma Josamycin Product Portfolio
- 4.9.5 SAJA Pharma Recent Developments
- 4.10 Ferrer International
- 4.10.1 Ferrer International Company Information
- 4.10.2 Ferrer International Business Overview
- 4.10.3 Ferrer International Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ferrer International Josamycin Product Portfolio
- 4.10.5 Ferrer International Recent Developments
- 4.11 Dragon Pharm
- 4.11.1 Dragon Pharm Company Information
- 4.11.2 Dragon Pharm Business Overview
- 4.11.3 Dragon Pharm Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Dragon Pharm Josamycin Product Portfolio
- 4.11.5 Dragon Pharm Recent Developments
- 4.12 Astellas
- 4.12.1 Astellas Company Information
- 4.12.2 Astellas Business Overview
- 4.12.3 Astellas Josamycin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Astellas Josamycin Product Portfolio
- 4.12.5 Astellas Recent Developments
5 Global Josamycin Market Scenario by Region
- 5.1 Global Josamycin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Josamycin Sales by Region: 2021-2032
- 5.2.1 Global Josamycin Sales by Region: 2021-2026
- 5.2.2 Global Josamycin Sales by Region: 2027-2032
- 5.3 Global Josamycin Revenue by Region: 2021-2032
- 5.3.1 Global Josamycin Revenue by Region: 2021-2026
- 5.3.2 Global Josamycin Revenue by Region: 2027-2032
- 5.4 North America Josamycin Market Facts & Figures by Country
- 5.4.1 North America Josamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Josamycin Sales by Country (2021-2032)
- 5.4.3 North America Josamycin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Josamycin Market Facts & Figures by Country
- 5.5.1 Europe Josamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Josamycin Sales by Country (2021-2032)
- 5.5.3 Europe Josamycin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Josamycin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Josamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Josamycin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Josamycin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Josamycin Market Facts & Figures by Country
- 5.7.1 South America Josamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Josamycin Sales by Country (2021-2032)
- 5.7.3 South America Josamycin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Josamycin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Josamycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Josamycin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Josamycin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Josamycin Sales by Type (2021-2032)
- 6.1.1 Global Josamycin Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Josamycin Sales Market Share by Type (2021-2032)
- 6.2 Global Josamycin Revenue by Type (2021-2032)
- 6.2.1 Global Josamycin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Josamycin Revenue Market Share by Type (2021-2032)
- 6.3 Global Josamycin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Josamycin Sales by Application (2021-2032)
- 7.1.1 Global Josamycin Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Josamycin Sales Market Share by Application (2021-2032)
- 7.2 Global Josamycin Revenue by Application (2021-2032)
- 7.2.1 Global Josamycin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Josamycin Revenue Market Share by Application (2021-2032)
- 7.3 Global Josamycin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Josamycin Value Chain Analysis
- 8.1.1 Josamycin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Josamycin Production Mode & Process
- 8.2 Josamycin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Josamycin Distributors
- 8.2.3 Josamycin Customers
9 Global Josamycin Analyzing Market Dynamics
- 9.1 Josamycin Industry Trends
- 9.2 Josamycin Industry Drivers
- 9.3 Josamycin Industry Opportunities and Challenges
- 9.4 Josamycin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst